Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

3.

Receptor-mediated mechanisms of lipoprotein remnant catabolism.

Chappell DA, Medh JD.

Prog Lipid Res. 1998 Dec;37(6):393-422. Review.

PMID:
10209655
4.

Chylomicron remnants: hepatic receptors and metabolism.

Havel RJ.

Curr Opin Lipidol. 1995 Oct;6(5):312-6. Review.

PMID:
8520854
5.

Mechanisms of hepatic chylomicron remnant clearance.

Willnow TE.

Diabet Med. 1997 Aug;14 Suppl 3:S75-80. Review.

PMID:
9272618
6.

Cell surface heparan sulfate proteoglycans and lipoprotein metabolism.

Kolset SO, Salmivirta M.

Cell Mol Life Sci. 1999 Nov 30;56(9-10):857-70. Review.

PMID:
11212344
7.

Hepatic uptake of chylomicron remnants.

Cooper AD.

J Lipid Res. 1997 Nov;38(11):2173-92. Review.

8.

[Familial type III hyperlipoproteinemia].

Kataoka S, Egusa G.

Nihon Rinsho. 2001 Mar;59 Suppl 3:69-73. Review. Japanese. No abstract available.

PMID:
11347154
9.

Remnant particles and their metabolism.

Eisenberg S, Sehayek E.

Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):739-53. Review.

PMID:
8593123
10.

Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism.

Bishop JR, Stanford KI, Esko JD.

Curr Opin Lipidol. 2008 Jun;19(3):307-13. doi: 10.1097/MOL.0b013e3282feec2d. Review.

PMID:
18460924
11.

Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors.

Beisiegel U, Heeren J.

Proc Nutr Soc. 1997 Jul;56(2):731-7. Review.

PMID:
9264123
12.

Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.

Beisiegel U.

Curr Opin Lipidol. 1995 Jun;6(3):117-22. Review.

PMID:
7647999
13.

Postprandial lipoproteins and atherosclerosis.

Yu KC, Cooper AD.

Front Biosci. 2001 Mar 1;6:D332-54. Review.

PMID:
11229885
14.

Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.

Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G.

Biochem Soc Trans. 2003 Oct;31(Pt 5):1070-4. Review.

PMID:
14505482
15.

Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism.

Havel RJ, Hamilton RL.

Hepatology. 1988 Nov-Dec;8(6):1689-704. Review.

PMID:
2847970
16.

Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.

Foley EM, Esko JD.

Prog Mol Biol Transl Sci. 2010;93:213-33. doi: 10.1016/S1877-1173(10)93010-X. Review.

PMID:
20807647
17.

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

Hyman BT, Strickland D, Rebeck GW.

Arch Neurol. 2000 May;57(5):646-50. Review.

PMID:
10815129
18.
19.

Hepatic lipase deficiency.

Connelly PW, Hegele RA.

Crit Rev Clin Lab Sci. 1998 Dec;35(6):547-72. Review.

PMID:
9885775
20.

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.

Shachter NS.

Curr Opin Lipidol. 2001 Jun;12(3):297-304. Review.

PMID:
11353333

Supplemental Content

Support Center